शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans

This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →

BSEMercury Laboratories Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Thu, 5 Nov, 2026 · 11:28 IST

Unaudited standalone Sep 2026 quarter net profit Rs 67.31 lakh; half-year profit down 63%

EBITDA margin compressionResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
—Next day
—
prior close
₹805.00
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used——
Pharmaceuticals peers, median of 172sector+0.4%—
Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
———+0.5—
Next day
———+0.4—
2d
—————
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Standalone quarter ended 30 September 2026: revenue from operations Rs 1,859.63 lakh, profit before tax Rs 91.61 lakh and profit after tax Rs 67.31 lakh; no year-ago quarter is shown. Standalone half year ended 30 September 2026: revenue Rs 3,420.89 lakh, profit after tax Rs 97.09 lakh and operating cash flow Rs 89.11 lakh, versus prior-half-year profit after tax Rs 261.09 lakh. Earlier-quarter figures were regrouped or reclassified.

Likely market impact

Positive quarterly profit helps, but half-year profit after tax fell 63% to Rs 97.09 lakh from Rs 261.09 lakh, weakening the earnings trend.

By the numbersStandalone · Q2 FY27 vs Q2 FY26
Q2 FY27Q2 FY26Change
Revenue₹19.01 Cr₹19.01 Cr+0.0%
Operating profit₹0.54 Cr₹1.13 Cr−52.5%
Profit after tax₹0.67 Cr₹1.64 Cr−59.0%
EBITDA margin7.6%11.2%−3.6 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.